IDH1 and central nervous system cancer: In regards to clinical features of gliomas (Table 1), V-ATPase G1 was more expressed by tumors wild-type for IDH1 enzyme (Figure 2C) whereas it did not correlate to MGMT promoter methylation (Supplementary Figure 5).